This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.
Iris Brewer, MS
Advertisement
Articles by Iris Brewer, MS
Advertisement
Latest Updated Articles
Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis CPublished: December 5th 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
5
